Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00266) | |||||
---|---|---|---|---|---|
Name |
Felbamate
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
felbamate; 25451-15-4; Felbatol; 2-Phenylpropane-1,3-diyl dicarbamate; 2-Phenyl-1,3-propanediol dicarbamate; Felbamyl; Taloxa; Felbamato; Felbamatum; 1,3-Propanediol, 2-phenyl-, dicarbamate; ADD-03055; UNII-X72RBB02N8; carbamic acid 2-phenyltrimethylene ester; CHEBI:4995; 3-(carbamoyloxy)-2-phenylpropyl carbamate; MLS000028465; X72RBB02N8; MFCD00865296; Felbamatum [Latin]; NCGC00015429-08; W-554;ADD-03055; Felbamato [Spanish]; SMR000058448; DSSTox_CID_3041; Felbamate [USAN:INN]; (3-carbamoyloxy-1,1,3,3-tetradeuterio-2-phenylpropyl) carbamate; DSSTox_RID_76847; DSSTox_GSID_23041; Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester; Felbatol (TN); CAS-25451-15-4; Carbamic acid, 2-phenyltrimethylene ester; (3-carbamoyloxy-2-phenylpropyl) carbamate; SR-01000000089; EINECS 247-001-4; BRN 3345236; Felbamete; HSDB 7525; Felbamate solution; ADD 03055; Felbamate (USPINN); Tocris-0869; Opera_ID_1738; Prestwick0_000919; Lopac-F-0778; Biomol-NT_000203; F 0778; CHEMBL1094; Lopac0_000524; SCHEMBL34947; 4-06-00-05993 (Beilstein Handbook Reference); MLS001077299; BIDD:GT0463; BPBio1_001258; GTPL5473; DTXSID9023041; AOB5042; EX-A591; HMS2093P19; HMS2234H06; HMS3261J09; HMS3266L12; HMS3370I06; HMS3411P21; HMS3657I11; HMS3675P21; HMS3715D20; HMS3884E11; Pharmakon1600-01505600; BCP27941; HY-B0184; ZINC1530803; Tox21_110145; Tox21_302368; Tox21_500524; 2-Phenyl-1,3-propanedioldicarbamate; ANW-65602; BDBM50088430; NSC759866; AKOS015895100; Tox21_110145_1; AC-8197; ACN-054465; CCG-204614; CS-2068; DB00949; KS-1171; LP00524; MCULE-2661497722; NSC-759866; SDCCGSBI-0050507.P003; NCGC00015429-01; NCGC00015429-02; NCGC00015429-03; NCGC00015429-04; NCGC00015429-05; NCGC00015429-06; NCGC00015429-07; NCGC00015429-09; NCGC00015429-10; NCGC00015429-11; NCGC00015429-14; NCGC00015429-24; NCGC00023092-02; NCGC00023092-04; NCGC00023092-05; NCGC00023092-06; NCGC00255275-01; NCGC00261209-01; SBI-0050507.P002; AB0011540; DB-046702; EU-0100524; FT-0630517; SW197633-2; (3-aminocarbonyloxy-2-phenyl-propyl) carbamate; C07501; D00536; J90036; K-6677; AB00382985-18; AB00382985_19; 451F154; A817858; Q421301; carbamic acid (3-carbamoyloxy-2-phenylpropyl) ester; Q-100326; SR-01000000089-2; SR-01000000089-4; SR-01000000089-7; BRD-K99107520-001-01-9; BRD-K99107520-001-09-2; BRD-K99107520-001-18-3; Z1541638522; Felbamate, United States Pharmacopeia (USP) Reference Standard
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Epilepsy | ICD-11: 8A60 | [1] | ||
PubChem CID | |||||
Formula |
C11H14N2O4
|
||||
Canonical SMILES |
C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N
|
||||
InChI |
1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)
|
||||
InChIKey |
WKGXYQFOCVYPAC-UHFFFAOYSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=3331"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 238.24 | Topological Polar Surface Area | 105 | |
XlogP | 0.6 | Complexity | 246 | ||
Heavy Atom Count | 17 | Rotatable Bond Count | 7 | ||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Felbamate 600 mg tablet | Click to Show/Hide the Full List of Formulation(s): 6 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c yellow no. 10; Fd&c red no. 40; Fd&c yellow no. 6; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Marlex Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c yellow no. 10; Fd&c red no. 40; Fd&c yellow no. 6; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Amneal Pharmaceuticals; Carilion Materials Management | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c yellow no. 10; Fd&c red no. 40; Magnesium stearate; Ferric oxide yellow; Povidone k30; Silicon dioxide; Cellulose, microcrystalline; Sodium starch glycolate type a potato; Starch, pregelatinized corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Cadila Healthcare; Zydus Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c yellow no. 10; Magnesium stearate; Croscarmellose sodium; Aluminum oxide; Microcrystalline cellulose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Taro Pharmaceuticals USA | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Alvogen; Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Ferric oxide yellow; Croscarmellose sodium; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | CorePharma; Impax Generics | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Felbamate 400 mg tablet | Click to Show/Hide the Full List of Formulation(s): 5 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; D&c yellow no. 10; Fd&c yellow no. 6; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Amneal Pharmaceuticals; Marlex Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Fd&c red no. 40; Magnesium stearate; Ferric oxide yellow; Povidone k30; Silicon dioxide; Cellulose, microcrystalline; Sodium starch glycolate type a potato; Starch, pregelatinized corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Cadila Healthcare; Zydus Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Alvogen; Mylan Pharamceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Ferric oxide yellow; Croscarmellose sodium; Cellulose, microcrystalline; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | CorePharma; Impax Generics | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose monohydrate; Magnesium stearate; Croscarmellose sodium; Microcrystalline cellulose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Taro Pharmaceuticals USA | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [4] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [4] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.